FDS, Inc. announced today the appointment of Adam McMullin as Chief Executive Officer (CEO), effective immediately. McMullin succeeds Jake Canova, who will continue to work with FDS in an advisory capacity after spending seven years as its CEO.
“We are very pleased to partner with Adam to lead FDS. His broad experience in healthcare IT will be invaluable as the company continues to innovate and grow in pharmacy technology and beyond,” said Michael Booth, a Partner with Calvert Street Capital Partners, FDS’s majority shareholder.